How has Xeris Biopharma Holdings, Inc.'s operating lease ROU assets changed year-over-year?

Xeris Biopharma Holdings, Inc.'s operating lease ROU assets decreased by 2.6% year-over-year, from $22.53M to $21.95M.

What does operating lease ROU assets mean?

Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Xeris Biopharma Holdings, Inc. XERS Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Corcept TherapeuticsCORT

8.3%-0.2pp

Eton Pharmaceuticals, Inc.ETON

$301K+90.5%

Crinetics PharmaceuticalsCRNX

8.6%-4,269,399,711pp

Catalyst PharmaceuticalCPRX

$1.86M-13.9%

BridgeBio PharmaBBIO

$17.23M+140%

LQD

Liquidia CorporationLQDA

$4.36M+5.5%

Other financials

Income statement

See full

Revenue$83.1M+38.3%

Gross profit$72.6M+41.2%

Operating income$7.9M+356%

Net income$2.2M+124%

EPS (diluted)$0.01+117%

Balance sheet

See full

Cash & equivalents$111.8M+91.2%

Total debt$258.6M-3.8%

Total equity$13.0M+137%

Total assets$392.0M+24.3%

Cash flow

See full

Operating cash flow$9.9M+198%

CapEx$131.0K—

Free cash flow-$29.1M—

Valuation

See full

Market cap$1.28B+18.3%

Enterprise value$1.42B+8.7%

P/E106.4×—

P/S4.1×-0.8×

Profitability

See full

Gross margin85.9%+3.7pp

Operating margin11.4%+7.7pp

Net margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-209.8%—

Debt / equity19.9×—

Current ratio2.1×+0.4×

Where this comes from

Reported directly by Xeris Biopharma Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s operating lease ROU assets?: Xeris Biopharma Holdings, Inc. (XERS) reported operating lease ROU assets of $21.95M in Q1 2026.
How has Xeris Biopharma Holdings, Inc.'s operating lease ROU assets changed year-over-year?: Xeris Biopharma Holdings, Inc.'s operating lease ROU assets decreased by 2.6% year-over-year, from $22.53M to $21.95M.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.